Live tape
Top 8, mentions 7d6,223META1,812 mentions▲ +0.06GOOGL1,253 mentions▲ +0.02NVDA720 mentions▲ +0.09MSFT539 mentions▲ +0.06MUSE508 mentions▲ +0.06TSLA481 mentions▲ +0.05SPY476 mentions▲ +0.04QQQ434 mentions▲ +0.07

Equity · Healthcare

ACHC

Acadia Healthcare Company, Inc. · NasdaqGS

$28 +0.65% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close) · Sep 25, 2026
Price · Chart
Our own end-of-day closes 61 sessions
$40 $25 1 Jul 25 Sep

The line runs $31.25 on 1 July through $28 on 25 September, on a scale from $25 to $40. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView

The chart above plots the price of ACHC over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 61 sessions over that window: $31.25 on 1 July 2026 through $28 on 25 September 2026.

Market cap $2.6B
52-week range $11.68 – $36
Avg volume 88.1K

Finazon · prior-day close, indicative (IEX-derived, not the official close) · valuation computed from SEC EDGAR filings · as of Sep 25, 2026

ACHC insider trades

SEC Form 4

ACHC has no Form 4 filing in the last 90 days, so there is no summary for that window. The most recent filings we hold are below, the newest dated 27 October 2025.

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
27 Oct 2025 YOUNG TODD S. Chief Financial Officer Award 48,445
30 Sep 2025 Khan Nasser Chief Operating Officer Tax withheld 973 $24K

ACHC reported financials

SEC EDGAR XBRL

ACHC reported revenue of $3.3B for the fiscal year ended 31 Dec 2025. Net income over the same period was −$1.1B.

Figure Reported Period
Revenue $3.3B 31 Dec 2025 fiscal year
Net income −$1.1B 31 Dec 2025 fiscal year
Diluted EPS −$12.16 31 Dec 2025 fiscal year
Total assets $5.5B 31 Mar 2026 at period end
Total equity $2.0B 31 Mar 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 31 Mar 2026

ACHC earnings

SEC EDGAR
Date Period EPS Revenue
31 Mar 2026 Q1 2026 $0.05 $829M
31 Dec 2025 FY 2025 $-12.16 $3.31B
30 Sep 2025 Q3 2025 $0.40 $852M
30 Jun 2025 Q2 2025 $0.33 $869M
31 Mar 2025 Q1 2025 $0.09 $771M
31 Dec 2024 FY 2024 $2.78 $3.15B
30 Sep 2024 Q3 2024 $0.74 $816M
30 Jun 2024 Q2 2024 $0.85 $796M

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

ACHC institutional holders

SEC Form 13F

8 of the 45 institutional funds we track reported a ACHC position for the quarter ended 30 Jun 2026 — a combined $110.3M; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
Citadel Advisors Held (±25%) −1.9% shares 2,665,603 $78.7M
Marshall Wace Added +74.4% shares 260,197 $7.7M
Man Group Trimmed −67.9% shares 255,147 $7.5M
Two Sigma Investments Held (±25%) −14.2% shares 181,274 $5.4M
AQR Capital Management Held (±25%) −21.1% shares 183,477 $5.2M
Tudor Investment Corp New position 80,204 $2.4M
Bridgewater Associates New position 63,439 $1.9M
D. E. Shaw & Co. Trimmed −41.6% shares 55,336 $1.6M
Maverick Capital Exited
Millennium Management Exited

Source: SEC EDGAR 13F filings

ACHC fails-to-deliver

SEC CNS data

On 27 Aug 2026, 52 shares of ACHC failed to deliver (about $2K).

Settlement date Shares failed Notional % of shares out
27 Aug 2026 52 $2K <0.001%
25 Aug 2026 1,056 $30K 0.001%
17 Aug 2026 56 $2K <0.001%

Source: SEC fails-to-deliver (CNS) data